Metagenomi, Inc. (MGX)
NASDAQ: MGX · IEX Real-Time Price · USD
6.89
-0.86 (-11.10%)
At close: Apr 19, 2024, 4:00 PM
6.50
-0.39 (-5.66%)
After-hours: Apr 19, 2024, 4:16 PM EDT

Metagenomi Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021
Revenue
44.7617.20.24
Revenue Growth (YoY)
160.21%6978.19%-
Gross Profit
44.7617.20.24
Selling, General & Admin
28.8518.79.71
Research & Development
94.443.1414.48
Operating Expenses
123.2561.8424.19
Operating Income
-78.49-44.64-23.95
Interest Expense / Income
00.10.3
Other Expense / Income
-18.26-3.71-2.81
Pretax Income
-60.23-41.02-21.44
Income Tax
8.032.570
Net Income
-68.26-43.59-21.44
Shares Outstanding (Basic)
333
Shares Outstanding (Diluted)
333
Shares Change
0.15%4.34%-
EPS (Basic)
-20.05-12.82-6.58
EPS (Diluted)
-20.05-12.82-6.58
Free Cash Flow
-101.2215.7521.35
Free Cash Flow Per Share
-29.734.636.55
Gross Margin
100.00%100.00%100.00%
Operating Margin
-175.38%-259.53%-9854.73%
Profit Margin
-152.50%-253.45%-8823.87%
Free Cash Flow Margin
-226.17%91.55%8787.65%
EBITDA
-51.81-37.9-19.82
EBITDA Margin
-115.77%-220.35%-8154.73%
Depreciation & Amortization
8.413.031.32
EBIT
-60.23-40.93-21.14
EBIT Margin
-134.57%-237.94%-8699.59%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).